Kenvue Inc. $KVUE Shares Sold by First Horizon Advisors Inc.

First Horizon Advisors Inc. trimmed its position in Kenvue Inc. (NYSE:KVUE) by 17.1% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 20,456 shares of the company’s stock after selling 4,231 shares during the period. First Horizon Advisors Inc.’s holdings in Kenvue were worth $428,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of KVUE. Evergreen Wealth Solutions LLC lifted its holdings in Kenvue by 2.6% during the 1st quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company’s stock worth $402,000 after buying an additional 432 shares during the last quarter. Wealth Alliance LLC lifted its stake in Kenvue by 1.6% during the first quarter. Wealth Alliance LLC now owns 31,778 shares of the company’s stock worth $762,000 after purchasing an additional 486 shares during the last quarter. Everett Harris & Co. CA lifted its stake in Kenvue by 1.4% during the first quarter. Everett Harris & Co. CA now owns 36,971 shares of the company’s stock worth $887,000 after purchasing an additional 500 shares during the last quarter. Proffitt & Goodson Inc. boosted its holdings in Kenvue by 8.2% in the second quarter. Proffitt & Goodson Inc. now owns 6,831 shares of the company’s stock worth $143,000 after purchasing an additional 517 shares during the period. Finally, UMB Bank n.a. increased its stake in Kenvue by 22.3% during the second quarter. UMB Bank n.a. now owns 2,853 shares of the company’s stock valued at $60,000 after purchasing an additional 521 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on KVUE. Rothschild Redb upgraded shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 26th. Rothschild & Co Redburn upgraded shares of Kenvue from a “neutral” rating to a “buy” rating and dropped their price objective for the stock from $22.50 to $22.00 in a research note on Friday, September 26th. Jefferies Financial Group decreased their target price on Kenvue from $25.00 to $23.00 and set a “buy” rating for the company in a research note on Monday, October 27th. Deutsche Bank Aktiengesellschaft set a $18.00 target price on Kenvue in a report on Friday, October 24th. Finally, UBS Group cut their price target on Kenvue from $23.00 to $17.00 and set a “neutral” rating on the stock in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, twelve have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Kenvue presently has an average rating of “Hold” and an average target price of $20.17.

Kenvue Price Performance

Shares of NYSE:KVUE opened at $16.90 on Friday. The firm’s 50 day moving average is $16.76 and its two-hundred day moving average is $20.30. The firm has a market capitalization of $32.37 billion, a P/E ratio of 22.53, a PEG ratio of 2.40 and a beta of 0.71. The company has a current ratio of 0.98, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $25.17.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The business had revenue of $3.76 billion during the quarter, compared to analyst estimates of $3.83 billion. During the same period in the prior year, the company posted $0.28 EPS. The business’s revenue for the quarter was down 3.5% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th will be given a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date is Wednesday, November 12th. Kenvue’s payout ratio is 110.67%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.